Zinc Gluconate and the Common Cold: a Controlled Clinical Study

13

description

The present study was carried out to test the hypothesis that pleasant-tasting zinc gluconate glycine lozenges that release 93% of the ionic zinc into saliva may produce similar efficacy to that originally reported by Eby et al in 1984, which successfully reduced the duration of the common cold using zinc gluconate.

Transcript of Zinc Gluconate and the Common Cold: a Controlled Clinical Study

Page 1: Zinc Gluconate and the Common Cold: a Controlled Clinical Study
Page 2: Zinc Gluconate and the Common Cold: a Controlled Clinical Study
Page 3: Zinc Gluconate and the Common Cold: a Controlled Clinical Study
Page 4: Zinc Gluconate and the Common Cold: a Controlled Clinical Study
Page 5: Zinc Gluconate and the Common Cold: a Controlled Clinical Study
Page 6: Zinc Gluconate and the Common Cold: a Controlled Clinical Study
Page 7: Zinc Gluconate and the Common Cold: a Controlled Clinical Study
Page 8: Zinc Gluconate and the Common Cold: a Controlled Clinical Study
Page 9: Zinc Gluconate and the Common Cold: a Controlled Clinical Study
Page 10: Zinc Gluconate and the Common Cold: a Controlled Clinical Study
Page 11: Zinc Gluconate and the Common Cold: a Controlled Clinical Study
Page 12: Zinc Gluconate and the Common Cold: a Controlled Clinical Study
Page 13: Zinc Gluconate and the Common Cold: a Controlled Clinical Study